[Stereotyped movements and substantia nigra-corpus striatum dopaminergic function in the rat: action of methylphenidate after inhibition of monoamine oxidase].
Duteil
J
J
de Sereville
J E
JE
Multon
M F
MF
Pessonnier
J
J
Rambert
F A
FA
D015102:3,4-Dihydroxyphenylacetic Acid / Q000378:metabolism; D000818:Animals; D003342:Corpus Striatum / Q000502:physiology*; D004298:Dopamine / Q000378:metabolism*; D008297:Male; D008774:Methylphenidate / Q000494:pharmacology*; D008996:Monoamine Oxidase Inhibitors; D010293:Pargyline / Q000494:pharmacology; D051381:Rats; D011916:Rats, Inbred F344; D011919:Rats, Inbred Strains; D013239:Stereotyped Behavior / Q000187:drug effects; D013378:Substantia Nigra / Q000502:physiology
D008996:Monoamine Oxidase Inhibitors; D015102:3,4-Dihydroxyphenylacetic Acid; D008774:Methylphenidate; D010293:Pargyline; D004298:Dopamine
Mouvements stéréotypés et fonctionnement dopaminergique nigro-strié ches le rat: action du méthylphénidate après inhibition de la monoamine-oxydase.